Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.

Mi Z, Abrahamson EE, Ryu AY, Fish KN, Sweet RA, Mufson EJ, Ikonomovic MD.

Neurobiol Aging. 2017 Jul;55:159-166. doi: 10.1016/j.neurobiolaging.2017.01.022. Epub 2017 Feb 4.

PMID:
28259365
2.

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.

Höglund K, Kern S, Zettergren A, Börjesson-Hansson A, Zetterberg H, Skoog I, Blennow K.

Transl Psychiatry. 2017 Jan 10;7(1):e995. doi: 10.1038/tp.2016.252.

3.

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.

Deming Y, Black K, Carrell D, Cai Y, Del-Aguila JL, Fernandez MV, Budde J, Ma S, Saef B, Howells B, Bertelsen S, Huang KL, Sutphen CL, Tarawneh R, Fagan AM, Holtzman DM, Morris JC, Goate AM, Dougherty JD, Cruchaga C.

BMC Neurol. 2016 Nov 10;16(1):217.

4.

The mismatch negativity as an index of cognitive decline for the early detection of Alzheimer's disease.

Ruzzoli M, Pirulli C, Mazza V, Miniussi C, Brignani D.

Sci Rep. 2016 Sep 12;6:33167. doi: 10.1038/srep33167.

5.

The Impact of Age on Cognition.

Murman DL.

Semin Hear. 2015 Aug;36(3):111-21. doi: 10.1055/s-0035-1555115.

6.

Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

Spangenberg EE, Green KN.

Brain Behav Immun. 2017 Mar;61:1-11. doi: 10.1016/j.bbi.2016.07.003. Epub 2016 Jul 6. Review.

PMID:
27395435
7.

Braak stage and trajectory of cognitive decline in noncognitively impaired elders.

Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE.

Neurobiol Aging. 2016 Jul;43:101-10. doi: 10.1016/j.neurobiolaging.2016.03.003. Epub 2016 Mar 10.

8.

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.

Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, Ances BM.

Sci Transl Med. 2016 May 11;8(338):338ra66. doi: 10.1126/scitranslmed.aaf2362.

9.

Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Scheff SW, Ansari MA, Mufson EJ.

Neurobiol Aging. 2016 Jun;42:1-12. doi: 10.1016/j.neurobiolaging.2016.02.030. Epub 2016 Mar 8.

10.

Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC.

Neurology. 2016 Apr 19;86(16):1499-506. doi: 10.1212/WNL.0000000000002593. Epub 2016 Mar 23.

11.

Brain aerobic glycolysis functions and Alzheimer's disease.

Vlassenko AG, Raichle ME.

Clin Transl Imaging. 2015 Feb 1;3(1):27-37. Epub 2014 Dec 10.

12.

Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease.

Brier MR, McCarthy JE, Benzinger TLS, Stern A, Su Y, Friedrichsen KA, Morris JC, Ances BM, Vlassenko AG.

Neurobiol Aging. 2016 Feb;38:104-111. doi: 10.1016/j.neurobiolaging.2015.10.025. Epub 2015 Oct 31.

13.

Characteristics of Tau and Its Ligands in PET Imaging.

Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y.

Biomolecules. 2016 Jan 6;6(1):7. doi: 10.3390/biom6010007. Review.

14.

Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Mufson EJ, Malek-Ahmadi M, Perez SE, Chen K.

Neurobiol Aging. 2016 Jan;37:147-153. doi: 10.1016/j.neurobiolaging.2015.10.012. Epub 2015 Oct 20.

15.

Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.

McGuinness B, Fuchs M, Barrett SL, Passmore AP, Johnston JA.

J Alzheimers Dis. 2016;49(4):1095-103. doi: 10.3233/JAD-150795.

16.

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.

Ishiki A, Okamura N, Furukawa K, Furumoto S, Harada R, Tomita N, Hiraoka K, Watanuki S, Ishikawa Y, Tago T, Funaki Y, Iwata R, Tashiro M, Yanai K, Kudo Y, Arai H.

PLoS One. 2015 Oct 13;10(10):e0140311. doi: 10.1371/journal.pone.0140311. eCollection 2015.

17.

Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium.

Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS.

Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.

18.

Alzheimer Lesions in the Autopsied Brains of People 30 to 50 Years of Age.

Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC.

Cogn Behav Neurol. 2015 Sep;28(3):144-52. doi: 10.1097/WNN.0000000000000071.

19.

Bivariate correlation coefficients in family-type clustered studies.

Luo J, D'Angela G, Gao F, Ding J, Xiong C.

Biom J. 2015 Nov;57(6):1084-109. doi: 10.1002/bimj.201400131. Epub 2015 Sep 11.

20.

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD.

Schindler SE, Fagan AM.

Front Neurol. 2015 Jun 29;6:142. doi: 10.3389/fneur.2015.00142. eCollection 2015. Review.

Supplemental Content

Support Center